-
Clinical Advantages of Atracurium Besylate: The Synergy of Dual Metabolic Pathways and Precision Anesthesia
Sep , 18 2025
Atracurium besylate, a distinguished neuromuscular blocking agent, stands out in anesthesia due to its dual metabolic pathways (Hofmann elimination and esterase hydrolysis) and precis...
read more